Advanced NanoTherapies’ SirPlux Duo Drug-Coated Balloon Receives FDA Breakthrough Designation for Small Vessel Coronary Artery Disease Read more
NICE Recommends BeiGene’s BRUKINSA (zanubrutinib) for Patients with Waldenström’s Macroglobulinemia who have had at Least One Treatment Read more
GENFIT to Acquire Clinical-stage Biopharmaceutical Company Versantis, expanding its Portfolio in Liver Diseases Read more
European Commission approves Roche’s Vabysmo, the first bispecific antibody for the eye, for two leading causes of vision loss Read more
Conference Co-Chairs Invite Medical Devices Experts to the Medical Devices & IVD Conference Read more
Evusheld long-acting antibody combination recommended for approval in the EU for the treatment of COVID-19 Read more
bluebird bio Receives FDA Accelerated Approval for SKYSONA Gene Therapy for Early, Active Cerebral Adrenoleukodystrophy (CALD) Read more
Bristol Myers Squibb Receives European Commission Approval for LAG-3-Blocking Antibody Combination, Opdualag (nivolumab and relatlimab), for the Treatment of Unresectable or Metastatic Melanoma with Tumor Cell PD-L1 Expression < 1% Read more
NeuroBo Pharmaceuticals, Inc. and Dong-A ST Co. Ltd. Announce Strategic Collaboration to License and Develop Portfolio of Dong-A’s Cardio-Metabolic Therapies Read more